Cargando…

Immunoglobulin Replacement Therapy During COVID-19 Pandemic: Practical and Psychological Impact in Patients with Antibody Deficiency

PURPOSE: The COVID-19 pandemic has impacted on how health services deliver care and the mental health of the population. Due to their clinical vulnerability, to reduce in-hospital attendances during the COVID-19 pandemic, modifications in immunoglobulin treatment regimens were made for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maimaris, Jesmeen, O’Sullivan, Anjel, Underhill, Isabella, Green, Ghiselle, Symes, Andrew, Lowe, David, Burns, Siobhan, Campbell, Mari, Elfeky, Reem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499672/ https://www.ncbi.nlm.nih.gov/pubmed/37357249 http://dx.doi.org/10.1007/s10875-023-01538-z

Ejemplares similares

Practical challenges for functional validation of STAT1 gain of function genetic variants
por: Albuquerque, Adriana S, et al.
Publicado: (2023)

Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma
por: Minskaia, Ekaterina, et al.
Publicado: (2023)

Adequate Patient’s Outcome Achieved with Short Immunoglobulin Replacement Intervals in Severe Antibody Deficiencies
por: Milito, Cinzia, et al.
Publicado: (2014)

Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin Therapy
por: Gonzalez, Juan Marcos, et al.
Publicado: (2022)

Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi‐organ autoimmunity
por: Blombery, Piers, et al.
Publicado: (2023)

Successful discontinuation of immunoglobulin G replacement at age 10 in a patient with immunoglobulin G2 deficiency
por: Shinjoh, Masayoshi, et al.
Publicado: (2017)

Fatigue Is Common in Immunoglobulin G Subclass Deficiency and Correlates With Inflammatory Response and Need for Immunoglobulin Replacement Therapy
por: Wågström, Per, et al.
Publicado: (2022)

Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency
por: Dinh, Tri, et al.
Publicado: (2019)

Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement
por: Duraisingham, Sai S., et al.
Publicado: (2014)

Effects of Immunoglobulin Replacement on Asthma Exacerbation in Adult Asthmatics with IgG Subclass Deficiency
por: Kim, Joo-Hee, et al.
Publicado: (2017)

Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency
por: Smits, Bas M., et al.
Publicado: (2020)

Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies
por: Cinetto, Francesco, et al.
Publicado: (2021)

Case of Fatal Meningitis in an Adult Patient with IRAK4 Deficiency
por: Verma, Nisha, et al.
Publicado: (2023)

Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese
por: Kan, Andy Ka Chun, et al.
Publicado: (2022)

Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia
por: Compagno, Nicolò, et al.
Publicado: (2014)

Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
por: Upasani, Vinit, et al.
Publicado: (2023)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
por: Canessa, Clementina, et al.
Publicado: (2016)

Considering Animals: Contemporary Studies in Human-Animal Relations
por: O’Sullivan, Siobhan
Publicado: (2012)

Secretarybird Sagittarius serpentarius Population Trends and Ecology: Insights from South African Citizen Science Data
por: Hofmeyr, Sally D., et al.
Publicado: (2014)

Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency
por: Hoffmann, F, et al.
Publicado: (2010)

Manufacture of Immunoglobulin Products for Patients with Primary Antibody Deficiencies – The Effect of Processing Conditions on Product Safety and Efficacy
por: Farrugia, Albert, et al.
Publicado: (2014)

Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity
por: Nicholson, Bethany, et al.
Publicado: (2022)

Immunoglobulin class-switch recombination deficiencies
por: Durandy, Anne, et al.
Publicado: (2012)

Hyperthyroidism with Selective Immunoglobulin A Deficiency
por: Harada, Ko, et al.
Publicado: (2018)

Principles of and Advances in Immunoglobulin Replacement Therapy for Primary Immunodeficiency
por: Berger, Melvin
Publicado: (2008)

Unusual presentation of a patient with complement deficiency and immunoglobulin deficiency
por: Manga, Vaishaali, et al.
Publicado: (2014)

Subcutaneous immunoglobulin replacement therapy in a patient with 18q deletion syndrome, primary immune deficiency, and type 1 diabetes
por: Hogendorf, Anna, et al.
Publicado: (2021)

Commissural alignment in transcatheter aortic valve replacement: A literature review
por: Khalid, Abdul Muiz, et al.
Publicado: (2022)

Bowel Histology of CVID Patients Reveals Distinct Patterns of Mucosal Inflammation
por: van Schewick, Cornelia M., et al.
Publicado: (2021)

British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapy
por: Grigoriadou, S, et al.
Publicado: (2022)

Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia
por: Ferrer, Gerardo
Publicado: (2018)

Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia
por: Ohmoto, Akihiro, et al.
Publicado: (2022)

541 Intravenous Immunoglobulin in Leukocyte Adhesion Deficiency
por: Oropeza, Said Arablin, et al.
Publicado: (2012)

Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland
por: Edgar, John David M., et al.
Publicado: (2018)

Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement
por: Weide, Rudolf, et al.
Publicado: (2020)

The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement
por: Cavaliere, Filomena Monica, et al.
Publicado: (2017)

Letter to the editor regarding: Plastic surgery training in the UK: Results from a national survey of trainee experiences (The taboo of aesthetic surgery and limitations placed on plastic surgical training)
por: O'Sullivan, Siobhan Ann, et al.
Publicado: (2021)

Remote yet engaging: Expanding learning opportunities through virtual platforms during the COVID-19 pandemic
por: Ann O'Sullivan, Siobhan, et al.
Publicado: (2021)

Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
por: Skoda-Smith, Suzanne, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_n0iu97hal94gh5hpgrpcipfhm0